We are live on ! Find out more
AMED

Amedisys
AMED

Delisted

AMED was delisted on the 14th of August, 2025.

Back to rankings

168 hedge funds and large institutions have $1.57B invested in Amedisys in 2016 Q2 according to their latest regulatory filings, with 21 funds opening new positions, 59 increasing their positions, 67 reducing their positions, and 21 closing their positions.

New
Increased
Maintained
Reduced
Closed

52% more call options, than puts

Call options by funds: $3.14M | Put options by funds: $2.07M

50% more funds holding in top 10

Funds holding in top 10: 2 → 3 (+1)

7% more capital invested

Capital invested by funds: $1.46B → $1.57B (+$108M)

0% more first-time investments, than exits

New positions opened: 21 | Existing positions closed: 21

1% less funds holding

Funds holding: 169 → 168 (-1)

12% less repeat investments, than reductions

Existing positions increased: 59 | Existing positions reduced: 67

Holders
168
Holders Change
-1
Holders Change %
-0.59%
% of All Funds
4.48%
Holding in Top 10
3
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+50%
% of All Funds
0.08%
New
21
Increased
59
Reduced
67
Closed
21
Calls
$3.14M
Puts
$2.07M
Net Calls
+$1.07M
Net Calls Change
+$3.32M

Top Buyers

1
Wells Fargo
Wells Fargo
California
+$79.1M
2
Marshall Wace
Marshall Wace
United Kingdom
+$6.26M
3
LOAMS
Lombard Odier Asset Management (Switzerland)
Switzerland
+$5.44M
4
NFA
Nationwide Fund Advisors
Ohio
+$5.33M
5
RIM
Rainier Investment Management
Washington
+$4.16M

Top Sellers

1
NTC
North Tide Capital
Massachusetts
-$24.2M
2
GAM
Gotham Asset Management
New York
-$8.99M
3
EAM
EverPoint Asset Management
Connecticut
-$7.49M
4
Bank of New York Mellon
Bank of New York Mellon
New York
-$5.99M
5
Adage Capital Partners
Adage Capital Partners
Massachusetts
-$4.83M
Name Holding Trade Value Shares
Change 		Change in
Stake
TCIM
26
TIAA CREF Investment Management
New York
$10.1M -$1.25M -24,680 -11%
Deutsche Bank
27
Deutsche Bank
Germany
$9.47M +$864K +17,113 +10%
BIM
28
BlackRock Investment Management
Delaware
$8.81M +$396K +7,848 +5%
Ameriprise
29
Ameriprise
Minnesota
$8.8M +$1.44M +28,472 +20%
Charles Schwab
30
Charles Schwab
California
$8.76M +$182K +3,600 +2%
Invesco
31
Invesco
Georgia
$8.37M +$1.17M +23,229 +16%
CM
32
Castleark Management
Illinois
$8M -$1.3M -25,840 -14%
PPA
33
Parametric Portfolio Associates
Washington
$7.67M -$681K -13,490 -8%
RCM
34
Riverhead Capital Management
Delaware
$7.44M +$215K +4,253 +69%
BlackRock
35
BlackRock
New York
$6.82M +$590K +11,685 +9%
HCMT
36
Highland Capital Management (Texas)
Texas
$6.29M -$4.61M -91,247 -42%
NFA
37
Nationwide Fund Advisors
Ohio
$6.26M +$5.33M +105,671 +578%
PAM
38
Panagora Asset Management
Massachusetts
$6.22M -$2.07M -41,080 -25%
FLAM
39
First Light Asset Management
Minnesota
$6.1M -$1.31M -26,040 -18%
PC
40
Pier Capital
Connecticut
$5.77M +$88.7K +1,757 +2%
Goldman Sachs
41
Goldman Sachs
New York
$5.54M +$2.44M +48,242 +78%
LOAMS
42
Lombard Odier Asset Management (Switzerland)
Switzerland
$5.44M +$5.44M +107,785 New
Morgan Stanley
43
Morgan Stanley
New York
$5.28M -$1.75M -34,666 -25%
California Public Employees Retirement System
44
California Public Employees Retirement System
California
$4.63M -$626K -12,400 -12%
Two Sigma Advisers
45
Two Sigma Advisers
New York
$4.63M -$1.58M -31,400 -26%
GF
46
Gerstein Fisher
New York
$4.61M +$999K +19,798 +28%
Millennium Management
47
Millennium Management
New York
$4.58M +$2.3M +45,640 +101%
TCM
48
Timpani Capital Management
Wisconsin
$4.46M -$140K -2,779 -3%
GCP
49
GSA Capital Partners
United Kingdom
$4.38M +$2.46M +48,800 +129%
AQR Capital Management
50
AQR Capital Management
Connecticut
$4.3M -$3.29M -65,170 -43%
1
2
3 4 5

AMED Hedge Fund Activity: Q2 2016 in Review

168 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Amedisys (AMED) for Q2 2016, worth a combined $1.57B — up 7.4% from $1.46B a quarter earlier.

Fund positioning in AMED was balanced in Q2 2016: 21 funds opened new positions, 21 closed out, 59 added to existing stakes and 67 trimmed.

The largest buyer was Wells Fargo, adding an estimated $79.1M. The largest seller was North Tide Capital, exiting entirely with an estimated $24.2M sold.

  • 168 institutional investors held Amedisys (AMED) as of Q2 2016, down from 169 in Q1 2016.
  • Funds reported $1.57B of Amedisys stock for Q2 2016, up 7.4% quarter-over-quarter.
  • 21 funds opened new Amedisys positions in Q2 2016 and 21 closed out, a net change of 0 holders.
  • The largest Amedisys buyer in Q2 2016 was Wells Fargo, an estimated $79.1M added.
  • The largest Amedisys seller in Q2 2016 was North Tide Capital, an estimated $24.2M sold.

Based on aggregated 13F filings for Q2 2016.